William E Russell

6PUBLICATIONS
33CO-AUTHORS
Medical biochemistry - proteins and peptides (incl. medical proteomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthFood properties (incl. characteristics and health benefits)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 24, 2026
Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure. Reply to Mallone R, Bandini A [letter].

Stephen E Gitelman, Kimber Simmons, Jennifer L Sherr

|Jan 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Carla J Greenbaum, S Alice Long, Stephen E Gitelman

|Nov 14, 2025
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.

Alfonso Galderisi, Alice L J Carr, Peter Taylor

|Nov 06, 2025
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes.

Stephen E Gitelman, Kimber Simmons, Jennifer L Sherr

|Oct 27, 2023
Response to Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013.

William E Russell, Daniel J Moore, Kevan C Herold

|Mar 15, 2023
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.

William E Russell, Brian N Bundy, Mark S Anderson

Pageof 1

Frequent Collaborators

4 joint publications

Jennifer L Sherr

4 joint publications

Kevan Herold

3 joint publications

Stephen E Gitelman

3 joint publications

Antoinette Moran